Piper Sandler & Co’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,000
Closed -$249K 37
2022
Q3
$249K Hold
25,000
0.2% 21
2022
Q2
$246K Hold
25,000
0.22% 23
2022
Q1
$245K Buy
+25,000
New +$244K 0.19% 18

Piper Sandler & Co's HCAR Position: Q4 2022 in Review

Piper Sandler & Co sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 25,000 shares — an estimated $249K sold.

Piper Sandler & Co first reported a position in HCAR in Q1 2022 and held it in 3 quarters. The position peaked at $249K in Q3 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

  • Piper Sandler & Co reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Piper Sandler & Co sold 25,000 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $249K.
  • Piper Sandler & Co first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Piper Sandler & Co's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $249K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Piper Sandler & Co's 13F filing for Q4 2022, filed 13 Feb 2023.